Ladderbio
Blue Bell, US · 2 known investors
Find your way into Ladderbio
860 people in our graph share verified history with the Ladderbio team — schools, employers, funds. One of them is your warm intro.
Kerry Killeenunlockedknows Heil Eric · together at University of Pennsylvania (overlapped)
×3knows the team · via The Wharton School
knows the team · via University of Pennsylvania
knows the team · via Easton Associates
×2knows the team · via Medical Excellence Capital
knows the team · via Health Quality Partners (HQP)
Ladder Bio (formerly ThirdLaw Molecular) develops Spiroligomer molecules, a class of synthetic, modular fused-ring compounds designed for highly selective binding to target proteins, along with computational design tools for targeted drug discovery. The platform is aimed at creating therapeutics and diagnostic tests as synthetic alternatives to peptides and antibodies.
Founders & leadership
CS
Christian SchafmeisterinFounder
Investors · 2
Founder mafia
2 people who came through Ladderbio went on to found or lead other companies.
Frequently asked questions
- What does Ladderbio do?
- Ladder Bio (formerly ThirdLaw Molecular) develops Spiroligomer molecules, a class of synthetic, modular fused-ring compounds designed for highly selective binding to target proteins, along with computational design tools for targeted drug discovery. The platform is aimed at creating therapeutics and diagnostic tests as synthetic alternatives to peptides and antibodies.
- Who founded Ladderbio?
- Ladderbio was founded by Christian Schafmeister.
- Who are Ladderbio's investors?
- Ladderbio's investors include Medical Excellence Capital, SmartGateVC.
- Where is Ladderbio headquartered?
- Ladderbio is headquartered in Blue Bell, US.